Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;28(10):1399.
doi: 10.1016/j.cmi.2022.04.024. Epub 2022 May 10.

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al

Nobuaki Mori  1
Affiliations
Comment

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al

Nobuaki Mori. Clin Microbiol Infect. 2022 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial.
    Bosaeed M, Alharbi A, Mahmoud E, Alrehily S, Bahlaq M, Gaifer Z, Alturkistani H, Alhagan K, Alshahrani S, Tolbah A, Musattat A, Alanazi M, Jaha R, Sultana K, Alqahtani H, Al Aamer K, Jaser S, Alsaedy A, Ahmad A, Abalkhail M, AlJohani S, Al Jeraisy M, Almaziad S, Albaalharith N, Alabdulkareem K, Alshowair A, Alharbi NK, Alrabiah F, Alshamrani M, Aldibasi O, Alaskar A. Bosaeed M, et al. Clin Microbiol Infect. 2022 Apr;28(4):602-608. doi: 10.1016/j.cmi.2021.12.026. Epub 2022 Jan 11. Clin Microbiol Infect. 2022. PMID: 35026375 Free PMC article. Clinical Trial.

References

    1. Bosaeed M., Alharbi1 A., Mahmoud E., Alrehily S., Bahlaq M., Gaifer Z., et al. Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial. Clin Microbiol Infect. 2022;28:602–608. - PMC - PubMed

LinkOut - more resources